Cargando…

WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic

Detalles Bibliográficos
Autores principales: Richards, K., Geoghegan, S., Butler, M., Shafi, N., Watson, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Cystic Fibrosis Society. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192164/
http://dx.doi.org/10.1016/S1569-1993(21)00994-2
_version_ 1783706000786718720
author Richards, K.
Geoghegan, S.
Butler, M.
Shafi, N.
Watson, D.
author_facet Richards, K.
Geoghegan, S.
Butler, M.
Shafi, N.
Watson, D.
author_sort Richards, K.
collection PubMed
description
format Online
Article
Text
id pubmed-8192164
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Cystic Fibrosis Society.
record_format MEDLINE/PubMed
spelling pubmed-81921642021-06-11 WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic Richards, K. Geoghegan, S. Butler, M. Shafi, N. Watson, D. J Cyst Fibros Workshops European Cystic Fibrosis Society. 2021 2021-06-11 /pmc/articles/PMC8192164/ http://dx.doi.org/10.1016/S1569-1993(21)00994-2 Text en Copyright © 2021 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Workshops
Richards, K.
Geoghegan, S.
Butler, M.
Shafi, N.
Watson, D.
WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic
title WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic
title_full WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic
title_fullStr WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic
title_full_unstemmed WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic
title_short WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic
title_sort ws14.2 potential factors influencing reduced requirements for intravenous antibiotics during the covid-19 pandemic
topic Workshops
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192164/
http://dx.doi.org/10.1016/S1569-1993(21)00994-2
work_keys_str_mv AT richardsk ws142potentialfactorsinfluencingreducedrequirementsforintravenousantibioticsduringthecovid19pandemic
AT geoghegans ws142potentialfactorsinfluencingreducedrequirementsforintravenousantibioticsduringthecovid19pandemic
AT butlerm ws142potentialfactorsinfluencingreducedrequirementsforintravenousantibioticsduringthecovid19pandemic
AT shafin ws142potentialfactorsinfluencingreducedrequirementsforintravenousantibioticsduringthecovid19pandemic
AT watsond ws142potentialfactorsinfluencingreducedrequirementsforintravenousantibioticsduringthecovid19pandemic